Notice: This company recently went public with an IPO on Friday, September 13th 2024. They issued 17,500,000 shares at $18.00 per share. We will continue to update data for BCAX as it becomes available. Bicara Therapeutics (BCAX) Competitors $25.73 -1.34 (-4.95%) (As of 09/18/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends BCAX vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying Bicara Therapeutics stock or one of its competitors? The main competitors of Bicara Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. Bicara Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote 180 Life Sciences (NASDAQ:ATNFW) and Bicara Therapeutics (NASDAQ:BCAX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends, profitability and community ranking. Which has higher earnings and valuation, ATNFW or BCAX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ABicara TherapeuticsN/AN/AN/AN/AN/A Does the media favor ATNFW or BCAX? In the previous week, Bicara Therapeutics had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Bicara Therapeutics and 2 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.44 beat Bicara Therapeutics' score of 0.33 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Bicara Therapeutics Neutral Do analysts prefer ATNFW or BCAX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABicara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community believe in ATNFW or BCAX? 180 Life Sciences and Bicara Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ABicara TherapeuticsN/AN/A Is ATNFW or BCAX more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Bicara Therapeutics N/A N/A N/A Summary180 Life Sciences and Bicara Therapeutics tied by winning 1 of the 2 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Bicara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCAX vs. The Competition Export to ExcelMetricBicara TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$207.55M$5.51B$8.27BDividend YieldN/A3.44%4.34%4.08%P/E RatioN/A322.91145.8818.58Price / SalesN/A12,033.551,698.4774.13Price / CashN/A12.0636.8431.89Price / BookN/A6.874.834.54Net IncomeN/A-$25.03M$115.08M$224.30M7 Day PerformanceN/A-0.98%4.03%5.57%1 Month PerformanceN/A3.52%9.54%8.86%1 Year PerformanceN/A11.29%29.09%12.05% Bicara Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNFW180 Life Sciences0 of 5 stars0.00 / 5 stars$0.01flatN/A-45.1%$0.00N/A0.007Positive NewsGap UpLBPSW4D pharma0 of 5 stars0.00 / 5 starsN/AN/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare Acquisition0 of 5 stars0.00 / 5 stars$0.04flatN/AN/A$0.00N/A0.002Gap UpAIMDWAinos0 of 5 stars0.00 / 5 stars$0.05flatN/A-66.9%$0.00$65,122.000.0040Positive NewsALVOWAlvotech0 of 5 stars0.00 / 5 stars$2.55flatN/AN/A$0.00$306.77M0.004Positive NewsALVOAlvotech2.8154 of 5 stars2.82 / 5 stars$10.81+0.1%$14.00+29.5%+20.5%$0.00$93.38M-5.201,026News CoverageACABWAtlantic Coastal Acquisition Corp. II0 of 5 stars0.00 / 5 stars$0.04flatN/A-14.4%$0.00N/A0.004Positive NewsGap DownACABUAtlantic Coastal Acquisition Corp. II0 of 5 stars0.00 / 5 stars$10.99flatN/AN/A$0.00N/A0.004Positive NewsBFRIWBiofrontera0 of 5 stars0.00 / 5 stars$0.03flatN/A-32.3%$0.00$35.24M0.0070Gap DownBTMDWbiote0 of 5 stars0.00 / 5 stars$0.34flatN/A-69.8%$0.00$187.23M0.00N/AGap Up Related Companies and Tools Related Companies: ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ALVO Competitors ACABW Competitors ACABU Competitors BFRIW Competitors BTMDW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BCAX) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCAX Stock Alerts